scorecardresearch
Add as a preferred source on Google
Saturday, April 4, 2026
TopicMylan

Topic: Mylan

Pharma giant Mylan wants hepatitis C drug’s clinical trial for Covid waived, regulator says no

Low-cost hepatitis C drugs sofosbuvir, used in combination with daclatasvir, has shown promise in reducing chance of death among hospitalised Covid patients.

How India’s culture of ‘jugaad’ is challenging the US drug agency

'Jugaad', translated as creative improvisation, is credited with the rise in technology and drug making in India. But it can have a darker connotation -- get it done at all costs.

On Camera

This is how Strait of Hormuz shock is forcing a global trade reset

The current Iran war has laid bare a fundamental reality: 20 per cent of global energy trade cannot afford to rely on a single artery, no matter how resilient and cost-effective.

SEBI proposes return of open market share buybacks to support stocks

Regulator seeks feedback on allowing firms to repurchase shares via exchanges after tax changes, as markets reel from war-led selloff and foreign outflows.

South Korea’s Cheongung-II missile system makes its mark in West Asia war. Here’s why

UAE has been using this defence system, which is similar to America's Patriots, against Iranian missiles and unmanned aerial vehicles.

China insulated itself against energy shocks. India is ‘all talk, no walk’

China patiently invested capital, skill and technology in coal gasification. Unlike it, we won’t move from words to action. As crude prices decline, we lose interest.